Alkermes ALKS
NASDAQ ALKS
$45.43 -0.06 (-0.13%)
As of: Sep 9, 2026 · 1:23 PM EDT

Alkermes (ALKS) Non Operating Income (2010 - 2026)

Alkermes' (ALKS) quarterly Non Operating Income came in at -$20.2 million in Q2 2026, down 270.55% year-over-year from $11.9 million in Q2 2025, and down 48.24% quarter-over-quarter from -$13.6 million in Q1 2026.

Analysis

Alkermes (ALKS) Non Operating Income (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Non Operating Income for 17 consecutive years, with -$20.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non Operating Income fell 270.55% year-over-year to -$20.2 million in Q2 2026; TTM through Jun 2026 was -$19.9 million, a 155.03% decrease from a year earlier, with the FY2025 full-year figure at $37.5 million, up 62.21% from the prior year.
  • Non Operating Income was -$20.2 million for Q2 2026 at Alkermes, down from -$13.6 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $11.9 million in Q2 2025 and troughed at -$20.2 million in Q2 2026.
  • A 5-year average of $505055.6 and a median of $2.9 million in 2023 frame the typical range for Non Operating Income.
  • Across the five-year window, Non Operating Income tumbled 729.04% in 2022 and surged 1120.71% in 2024, its largest moves.
  • Over 5 years, Non Operating Income stood at -$1.1 million in 2022, then soared by 433.18% to $3.7 million in 2023, then surged by 95.41% to $7.2 million in 2024, then sank by 68.43% to $2.3 million in 2025, then plunged by 989.97% to -$20.2 million in 2026.
  • The last three Non Operating Income figures came in at -$20.2 million (Q2 2026), -$13.6 million (Q1 2026), and $2.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 644.32 Bn 623.56 Bn 17.26 Bn -
2 AbbVie 440.60 Bn 434.04 Bn 12.70 Bn -
3 Merck 365.39 Bn 358.25 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -
5 Pfizer 159.22 Bn 147.52 Bn 10.94 Bn -
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn -
7 Revolution Medicines 44.21 Bn 44.21 Bn - -139.24 Mn
8 Incyte 25.34 Bn 20.81 Bn 1.57 Bn -
9 United Therapeutics 21.49 Bn 18.82 Bn 683.80 Mn 41.90 Mn
10 Alkermes 7.58 Bn 6.93 Bn 397.90 Mn -20.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.23 Mn
Mar 31, 2026 -13.65 Mn
Dec 31, 2025 2.27 Mn
Sep 30, 2025 11.66 Mn
Jun 30, 2025 11.86 Mn
Mar 31, 2025 11.70 Mn
Dec 31, 2024 7.20 Mn
Sep 30, 2024 5.47 Mn
Jun 30, 2024 6.84 Mn
Mar 31, 2024 3.60 Mn
Dec 31, 2023 3.69 Mn
Sep 30, 2023 3.51 Mn
Jun 30, 2023 560,000.00
Mar 31, 2023 -361,000.00
Dec 31, 2022 -1.11 Mn
Sep 30, 2022 -6.73 Mn
Jun 30, 2022 1.21 Mn
Mar 31, 2022 -18.41 Mn
Dec 31, 2021 -2.16 Mn
Sep 30, 2021 -6.88 Mn